UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing

Clinical genetics, 2015-03, Vol.87 (3), p.225-232

2015

Volltextzugriff (PDF)

Frequency and long-term impact of myonecrosis after coronary stenting

European heart journal, 2002-06, Vol.23 (11), p.869-876

2002

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

European heart journal, 2002-09, Vol.23 (18), p.1441-1448

2002

Volltextzugriff (PDF)

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

European heart journal, 2000-11, Vol.21 (21), p.1750-1758

2000

Volltextzugriff (PDF)

The impact of fibrinolytic therapy for ST‐segment‐elevation acute myocardial infarction

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.14-20

2009

Volltextzugriff (PDF)

The early history and development of thrombolysis in acute myocardial infarction

Journal of thrombosis and haemostasis, 2004-11, Vol.2 (11), p.1867-1870

2004

Volltextzugriff (PDF)

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

European heart journal, 2004-02, Vol.25 (4), p.313-321

2004

Volltextzugriff (PDF)

Physicians and the investment industry

American journal of ophthalmology, 2005-09, Vol.140 (3), p.567-567

2005

Volltextzugriff (PDF)

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

European heart journal, 2003-01, Vol.24 (2), p.182-189

2003

Volltextzugriff (PDF)

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

European heart journal, 2000-12, Vol.21 (23), p.1928-1936

2000

Volltextzugriff (PDF)

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

European heart journal, 2003-01, Vol.24 (2), p.172-181

2003

Volltextzugriff (PDF)

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

European heart journal, 2000-03, Vol.21 (5), p.371-381

2000

Volltextzugriff (PDF)

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III

European heart journal, 1999-01, Vol.20 (2), p.128-135

1999

Volltextzugriff (PDF)

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

European heart journal, 2002-02, Vol.23 (3), p.239-246

2002

Volltextzugriff (PDF)

The TARGET trial: hit or miss?

European heart journal, 2002-06, Vol.23 (11), p.835-837

2002

Volltextzugriff (PDF)

Troponin, embolization and restoration of microvascular integrity

European heart journal, 2000-07, Vol.21 (14), p.1117-1119

2000

Volltextzugriff (PDF)

Epicardial versus microcirculatory dissociation

European heart journal, 2002-02, Vol.23 (4), p.274-276

2002

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?

European heart journal, 2000-06, Vol.21 (11), p.863-867

2000

Volltextzugriff (PDF)

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

American journal of ophthalmology, 2006-08, Vol.142 (2), p.366-366

2006

Volltextzugriff (PDF)

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction

European heart journal, 2003-10, Vol.24 (20), p.1807-1814

2003

Volltextzugriff (PDF)

Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes

European heart journal, 2002-08, Vol.23 (15), p.1202-1212

2002

Volltextzugriff (PDF)

Particular benefit of platelet GPIIb/IIIa blockade and full heparin in patients with peripheral vascular disease undergoing PTCA

Journal of the American College of Cardiology, 1998-02, Vol.31, p.455-455

1998

Volltextzugriff (PDF)

Does periprocedural MI during PTCA reduce subsequent clinical restenosis?

Journal of the American College of Cardiology, 1998-02, Vol.31, p.417-417

1998

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia syndrome complicating percutaneous coronary intervention

Journal of the American College of Cardiology, 1998-02, Vol.31, p.457-457

1998

Volltextzugriff (PDF)

Disagreement between site investigators and clinical event committees is common and can affect trial results

Journal of the American College of Cardiology, 1998, Vol.31, p.184-185

1998

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(61)

Sprache

Englisch
(60)
Spanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing

Frequency and long-term impact of myonecrosis after coronary stenting

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

The impact of fibrinolytic therapy for ST‐segment‐elevation acute myocardial infarction

The early history and development of thrombolysis in acute myocardial infarction

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

Physicians and the investment industry

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

The TARGET trial: hit or miss?

Troponin, embolization and restoration of microvascular integrity

Epicardial versus microcirculatory dissociation

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction

Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes

Particular benefit of platelet GPIIb/IIIa blockade and full heparin in patients with peripheral vascular disease undergoing PTCA

Does periprocedural MI during PTCA reduce subsequent clinical restenosis?

Heparin-induced thrombocytopenia syndrome complicating percutaneous coronary intervention

Disagreement between site investigators and clinical event committees is common and can affect trial results

Suchergebnisse filtern